| Stage | MTX | % of rev | LIN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $555M | 100.00% | $9.4B | 100.00% | LIN ×16.95 |
| Gross profit | $129M | 23.28% | $4.4B | 47.24% | LIN +24.0pp |
| Operating income | $65M | 11.68% | $2.1B | 22.86% | LIN +11.2pp |
| Pre-tax income | $53M | 9.55% | $2.1B | 22.63% | LIN +13.1pp |
| Net income | $44M | 7.89% | $1.7B | 18.50% | LIN +10.6pp |
| Stage | MTX | LIN | Gap · A − B |
|---|---|---|---|
| Revenue | $555M100.00% | $9.4B100.00% | LIN ×16.95 |
| Gross profit | 23.28%$129M | 47.24%$4.4B | LIN +24.0pp |
| Operating income | 11.68%$65M | 22.86%$2.1B | LIN +11.2pp |
| Pre-tax income | 9.55%$53M | 22.63%$2.1B | LIN +13.1pp |
| Net income |
| 7.89%$44M |
| 18.50%$1.7B |
| LIN +10.6pp |